BioPharm International
January 01, 2019
From the Editor
32
1
Pricing pressures, investment volatility, and government disfunction greet Biopharma in 2019.
January 01, 2019
Features
32
1
For rapid scale-up of biomanufacturing under expedited review status, facility design must better integrate product development and manufacturing lifecycle activities.
January 01, 2019
Features
32
1
Compensation and professional challenges are key pieces to solving the biopharma employee satisfaction puzzle.
January 01, 2019
Cover Story
32
1
Bio/pharma companies are successfully launching novel therapies; however, the industry still needs to work on manufacturing innovation.
January 01, 2019
Features
32
1
Kinetic models can be used to study aggregation and fragmentation to help ensure stability.
January 01, 2019
Downstream Processing
32
1
New ligands are being developed to meet the separation and purification needs of next-gen biologics.
January 01, 2019
Upstream Processing
32
1
Automation in cell-line development and cell culture is leading to more consistent quality while improving efficiency, and, ultimately, speed to market.
January 01, 2019
Regulatory Beat
32
1
FDA plans to support initiatives to ensure that all medicines are safe, effective, and of high quality.
January 01, 2019
Ask the Expert
32
1
Understanding the differences in inspection processes is the key to successful global expansion, according to Siegfried Schmitt, PhD, vice-president Technical, PAREXEL Consulting.
January 01, 2019
Perspectives on Outsourcing
32
1
Outsourcing of manufacturing activities is expected to increase in 2019.
January 01, 2019
Peer-Reviewed Research
32
1
A key technology that can help achieve a continuous production flow is single-pass tangential flow filtration.
January 01, 2019
Issue PDF
32
1
Click the title above to open the BioPharm International January 2019 issue in an interactive PDF format.